newsfilter
← Latest News
GlobeNewswire·

CytoDyn Releases ESMO Breast Cancer Meeting Poster

VANCOUVER, Washington, May 15, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for